$AMTM

Amentum Holdings FY26 Guidance: Sales and EPS miss analyst estimates

Amentum Holdings (NYSE: AMTM) issued FY2026 guidance. It expects adjusted EPS of $2.40 to $2.50 versus a $2.42 analyst consensus, and sales of $13.800B to $13.950B versus $14.141B. The company’s forecast implies weaker revenue and limited upside versus estimates.

Original reporting
Published Aug 10, 2026, 9:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:34 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Amentum Holdings FY26 Guidance: Sales and EPS miss analyst estimates — source image
Decision brief

The 30-second read

$AMTMBearishMed
01

Why it matters

Because both guided sales and the lower EPS bound are below/under consensus, traders may reprice near-term revenue growth expectations and adjust forward estimates until new contract award visibility emerges.

02

Market read

This is a company-specific guidance miss versus consensus, with the sales range entirely below the analyst estimate, creating a clear catalyst for repricing.

03

What to watch

The article does not break out backlog, contract awards, or margin drivers, so the market may overreact to sales alone without knowing whether profitability is protected by mix or cost controls.

Relevance 8/10Novelty 7/10Timing: after-hours guidance update dated 2026-08-10

Background

The article reports Amentum Holdings’ FY2026 guidance for adjusted EPS and total sales, explicitly comparing both to analyst consensus.

Company-level read

Ticker impact

$AMTMBearishMedium confidence
Context

Amentum guided FY2026 adjusted EPS to $2.40 to $2.50 and sales to $13.80B to $13.95B, both below consensus.

Expected impact

Likely negative bias for the stock on guidance-miss interpretation, with follow-through risk if investors focus on the sales shortfall.

Evidence & confidence

The article provides explicit FY2026 ranges and compares them to analyst consensus, with the sales range entirely below the estimate, which typically pressures valuation multiples for defense services names.

Market effects

Amentum’s conservative FY2026 sales outlook may reinforce caution around defense services contract timing and execution risk across the sector.

Limited direct regional spillover beyond US defense contractors and services sentiment.

Modest, as the disclosure is company-specific and not a broad procurement or geopolitical policy change.

Counterpoint

The EPS range straddles consensus ($2.42) and the upper end ($2.50) could still support the stock if investors believe revenue softness is temporary.

Key entities

  • Amentum Holdings

    Defense and national security services provider issuing FY2026 guidance that misses analyst consensus on sales and is mixed on EPS.

Related articles

$AMTMMed

Why Amentum (AMTM) Shares Are Trading Lower Today

Amentum Holdings (NYSE: AMTM) shares fell about 6% after the company’s Q3 results missed Wall Street expectations. Revenue was $3.49B, down 2% and below the $3.57B consensus. GAAP EPS was $0.27, also below estimates. Backlog rose 8.1% y/y, but investors focused on weaker revenue and profit.

$AMTMMedAI 8/10

Amentum Reports Third Quarter Fiscal Year 2026 Results

Amentum Holdings (NYSE: AMTM) reported third-quarter FY2026 revenue of $3.49 billion, down 2% year over year. Net income was $66 million, with adjusted EBITDA of $290 million and adjusted diluted EPS of $0.67. Operating cash flow was $146 million and free cash flow $135 million. Backlog rose to $48.2 billion, with book-to-bill of 1.1x.